CAM
BIIB icon

Covenant Asset Management’s Biogen BIIB Stock Holding History

Covenant Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,000
Closed -$1.71M – 147
2020
Q4 		$1.71M Hold
7,000
– – 0.56% 54
2020
Q3 		$1.99M Hold
7,000
– – 0.64% 47
2020
Q2 		$1.87M Hold
7,000
– – 0.41% 50
2020
Q1 		$2.21M Buy
+7,000
New +$2.12M 0.67% 34

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Covenant Asset Management's BIIB Position: Q4 2021 in Review

Covenant Asset Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 794 shares — an estimated $225K sold.

Covenant Asset Management first reported a position in BIIB in Q4 2016 and held it in 19 quarters. The position peaked at $3.64M in Q4 2016. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Covenant Asset Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Covenant Asset Management sold 794 Biogen shares in Q4 2021, an estimated $225K.
  • Covenant Asset Management first reported a position in Biogen in Q4 2016 and held it in 19 quarters.
  • Covenant Asset Management's Biogen position peaked at $3.64M in Q4 2016.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Covenant Asset Management's 13F filing for Q4 2021, filed 26 Jan 2022.